Product logins

Find logins to all Clarivate products below.


Aesthetic Injectables | Market Insights | Europe (Supplemental) | 2021

Although it will be negatively affected by the COVID-19 pandemic in the short term, the European aesthetic injectables market will grow rapidly through 2029, driven by increasing penetration into new patient groups, such as men and younger patients, as well as major M&As in the aesthetics space. The new advancements and products offered by competitors, along with their efforts to distinguish their products, will help the market to expand, though growth will decelerate to some extent.

This Medtech 360 Report provides high-level market metrics for aesthetic injectables in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.

Related Medtech Insights Reports

Report
Peripheral Vascular Devices – Market Insights – Europe
The European PV device market will be mainly driven by the increasing availability of premium-priced products and emerging products which, supported by clinical data, will increase the penetration…
Report
Breast Implants and Reconstructive Devices – Market Insights – United States
The US breast implant and reconstructive device market is projected to grow steadily through 2034, driven by the rising incidence of breast cancer, established screening guidelines, and increasing…
Report
Physician-Dispensed Cosmeceuticals – Market Insights – United States
The US physician-dispensed cosmeceuticals market will experience robust growth through the forecast period. The expansion is fueled by rising demand for aesthetic procedures, growing consumer…
Report
Aesthetic Energy-Based Devices – Market Insights – United States
Aesthetic energy-based device procedure volumes will be supported by the trend toward minimally invasive and noninvasive treatments. As a result, companies are investing in developing such devices…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…